These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7194645)

  • 1. In vivo and in vitro detection of induced resistance to daunorubicin in murine leukemia L 1210.
    Volm M; Maas E; Mattern J
    Arzneimittelforschung; 1981; 31(2):300-2. PubMed ID: 7194645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.
    Slater LM; Sweet P; Stupecky M; Gupta S
    J Clin Invest; 1986 Apr; 77(4):1405-8. PubMed ID: 3457021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination antifol therapy: observations on the development of resistant L1210 leukemic cells in vivo.
    Browman GP; Lazarus H
    Cancer Treat Rep; 1980; 64(2-3):231-6. PubMed ID: 7407755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
    Edelstein M; Vietti T; Valeriote F
    Cancer Res; 1974 Feb; 34(2):293-7. PubMed ID: 4810905
    [No Abstract]   [Full Text] [Related]  

  • 5. Overcoming of vincristine resistance in L1210/VCR cells by several corticosteroids. Collateral sensitivity of resistant cells.
    Barancík M; Docolomanský P; Slezák J; Breier A
    Neoplasma; 1993; 40(1):21-5. PubMed ID: 7688866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
    Marchini S; Damia G; Broggini M; Pennella G; Ripamonti M; Marsiglio A; Geroni C
    Cancer Res; 2001 Mar; 61(5):1991-5. PubMed ID: 11280757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of daunorubicin resistance in P388/ADR cells by itraconazole.
    Gupta S; Kim J; Gollapudi S
    J Clin Invest; 1991 Apr; 87(4):1467-9. PubMed ID: 1849151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
    Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of new N-substituted daunorubicin derivatives.
    Mazerska Z; Woynarowska B; Stefanska B; Borowski E; Martelli S
    Drugs Exp Clin Res; 1987; 13(6):345-51. PubMed ID: 3308387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal effects of several Ca(2+)-entry blockers, neuroleptics and local anaesthetics on P-glycoprotein-mediated vincristine resistance of L1210/VCR mouse leukaemic cell line.
    Barancík M; Poleková L; Mrázová T; Breier A; Stankovicová T; Slezák J
    Drugs Exp Clin Res; 1994; 20(1):13-8. PubMed ID: 7924890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liposome encapsulation as a possibility for the improvement of tumor chemotherapy].
    Fichtner I; Reszka R; Elbe B; Arndt D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):658-63. PubMed ID: 6172330
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia.
    Fodstad O; Pihl A
    Cancer Res; 1982 Jun; 42(6):2152-8. PubMed ID: 7200398
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquisition of multidrug resistance by L1210 leukemia cells decreases their tumorigenicity and enhances their susceptibility to the host immune response.
    Martín-Orozco E; Ferragut JA; Garcia-Peñarrubia P; Ferrer-Montiel A
    Cancer Immunol Immunother; 2005 Apr; 54(4):328-36. PubMed ID: 15692844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line.
    Breier A; Barancík M; Stefanková Z; Uhrík B; Tribulová N
    Neoplasma; 1994; 41(5):297-303. PubMed ID: 7854500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of development of resistance in the short-term test (author's transl].
    Volm M; Maass E
    Blut; 1979 Oct; 39(4):289-92. PubMed ID: 497409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression.
    Breier A; Stefanková Z; Barancík M; Tribulová N
    Gen Physiol Biophys; 1994 Aug; 13(4):287-98. PubMed ID: 7890145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of murine leukemia antigen on L1210 parental and drug-resistant sublines.
    Strzadala L; Opolski A; Radzikowski C; Mihich E
    Cancer Res; 1981 Dec; 41(12 Pt 1):4934-7. PubMed ID: 7306993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.